Cell-derived Membrane Biomimetic Nanocarriers for Targeted Therapy of Pulmonary Disease

Xixi Zheng,Tianyuan Zhang,Ting Huang,Yanjun Zhou,Jianqing Gao
DOI: https://doi.org/10.1016/j.ijpharm.2022.121757
IF: 6.51
2022-01-01
International Journal of Pharmaceutics
Abstract:Pulmonary diseases are currently one of the major threats of human health, especially considering the recent COVID-19 pandemic. However, the current treatments are facing the challenges like insufficient local drug concentrations, the fast lung clearance and risks to induce unexpected inflammation. Cell-derived membrane biomimetic nanocarriers are recently emerged delivery strategy, showing advantages of long circulation time, excellent biocompatibility and immune escape ability. In this review, applications of using cell-derived membrane biomimetic nanocarriers from diverse cell sources for the targeted therapy of pulmonary disease were summarized. In addition, improvements of the cell-derived membrane biomimetic nanocarriers for augmented therapeutic ability against different kinds of pulmonary diseases were introduced. This review is expected to provide a general guideline for the potential applications of cell-derived membrane biomimetic nanocarriers to treat pulmonary diseases.
What problem does this paper attempt to address?